Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Malignant Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01265810
What this trial is testing

Caphosol in Oral Mucositis Due to Targeted Therapy

Who this might be right for
Oral ComplaintsRenal Cell CarcinomaHepatocellular Carcinoma+1 more
Impaqtt Foundation 64
Testing effectiveness (Phase 2)Looking for participantsNCT03175224
What this trial is testing

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced CancerRenal Cancer+15 more
Apollomics Inc. 497
Testing effectiveness (Phase 2)Ended earlyNCT02853162
What this trial is testing

Ablative tReatment of Inoperable REnal Cell Carcinoma Using STereotactic Body Radiotherapy (ARREST-study)

Who this might be right for
Renal Cell Carcinoma
UMC Utrecht 30
Testing effectiveness (Phase 2)Study completedNCT03526250
What this trial is testing

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more
National Cancer Institute (NCI) 23
Early research (Phase 1)Study completedNCT04846920
What this trial is testing

Belzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 29
Early research (Phase 1)Study completedNCT00036959
What this trial is testing

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Institutes of Health Clinical Center (CC) 90
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Not applicableActive Not RecruitingNCT04258813
What this trial is testing

Onco-primary Care Networking to Support TEAM-based Care

Who this might be right for
Blood PressureHypertensionCancer+15 more
Duke University 313
Testing effectiveness (Phase 2)Active Not RecruitingNCT06584435
What this trial is testing

Toripalimab in Adjuvant Therapy After Resection of High-risk Renal Cancer

Who this might be right for
High-risk Renal Cell Carcinoma
Tianjin Medical University Second Hospital 100
Not applicableUnknownNCT04392076
What this trial is testing

Image Guided RFA/MWA/CRYO of RCC Biomarker Profile Study

Who this might be right for
Renal Cancer
University of Leeds 43
Testing effectiveness (Phase 2)Study completedNCT03587662
What this trial is testing

Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Metastatic Kidney Medullary CarcinomaMetastatic Renal Cell CarcinomaSMARCB1 Negative+2 more
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT00934440
What this trial is testing

Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
University of Kansas Medical Center 11
Post-approval studies (Phase 4)Study completedNCT00666978
What this trial is testing

Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Lisa Sanderson Cox, PhD 540
Not applicableStudy completedNCT03064308
What this trial is testing

The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery

Who this might be right for
Impaired CognitionQuality of LifeSurgery+7 more
University of Nottingham 11
Not applicableStudy completedNCT07004426
What this trial is testing

Symptomatic and Incidental RCC Detection

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)Benign Renal NeoplasmRenal Carcinoma
Charles University, Czech Republic 1,000
Not applicableEnded earlyNCT02131376
What this trial is testing

Investigating a Novel Modifiable Factor Affecting Renal Function After Partial Nephrectomy: Cortical Renorrhaphy

Who this might be right for
Renal Cell Carcinoma
Indiana University 26
Testing effectiveness (Phase 2)Study completedNCT00057889
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer

Who this might be right for
Kidney Cancer
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT00563147
What this trial is testing

A Phase 1b, Open-Label, Dose-Finding Study to Evaluate the Safety of Tivozanib (AV-951) in Combination With Temsirolimus in Subjects With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
AVEO Pharmaceuticals, Inc. 28
Early research (Phase 1)Active Not RecruitingNCT04163289
What this trial is testing

Preventing Toxicity in Renal Cancer Patients Treated With Immunotherapy Using Fecal Microbiota Transplantation

Who this might be right for
Renal Cell Carcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 20
Not applicableEnded earlyNCT04147143
What this trial is testing

CaboCHECK - Cabozantinib in Adult Patients With Advanced Renal Cell Carcinoma Following Prior Systemic Check Point Inhibition Therapy: a Retrospective, Non-interventional Study

Who this might be right for
Advanced Renal Cell Carcinoma (All Subtypes)Metastatic Renal Cell Carcinoma (All Subtypes)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 56
Next Page